Passive intracranial pressure sensor for hydrocephalus shunts and cranioplasty implants with ultrasound readout
Award amount
$255,781Program and phase
SBIR · Phase IAward year
2022Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- SENTIOMED, INC.
- Proposal award date
- 2022-04-01
- Contract end date
- 2023-03-31
- UEI
- HJVMCLNHEZ49
- Solicitation number
- PA21-259
- Topic code
- 108
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- SBIR Phase I:Sentiomed Injectable 14-day Biodegradable Glucose Sensor System
- Continuous real-time fentanyl sensor platform based on smart hydrogels for application in anesthesia
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- PHASE II DEVELOPMENT OF RAPID MOLECULAR ASSAY FOR POINT OF CARE DETECTION OF TREPONEMA PALLIDUM
- Assessment of Deep Learning Classification Methods for Parkinsonism
- Discovery of GPR171 small molecule ligands for the treatment of chronic pain
- Targeting TLR4-lipid rafts to prevent postoperative pain
- SBIR TOPIC 108, FAST-TRACK - DEVICE SYSTEM FOR TRANSCATHETER REPAIR OF POSTINFARCTION VENTRICULAR SEPTAL DEFECT
Research funding history
3 SBIR/STTR records share this UEI (2019–2022). Reported award amounts total $734,642. Reported amounts are not federal obligations.
Phases: Phase I
Agencies: Department of Health and Human Services, National Science Foundation